Changes in Director's Interest (Section 219 of CA 2016)
| NOVA PHARMA SOLUTIONS BERHAD |
Information Compiled By KLSE
Particulars of Director
| Name | MR GAN YEE HIN |
| Descriptions(Class) | Ordinary Shares |
Details of changes
| No | Date of change |
No of securities |
Type of transaction |
Nature of Interest |
|
06/03/2026
|
87,976,007
|
Others
|
Indirect Interest
|
|
| Name of registered holder | SOUTHERN SCORE BUILDERS BERHAD | |||
| Description of "Others" Type of Transaction | Appointment as Dir | |||
| Consideration (if any) | ||||
| Circumstances by reason of which change has occurred | Appointment as Executive Director of the Company |
| Nature of interest | Indirect Interest |
Total no of securities after change |
|
| Direct (units) | 0 |
| Direct (%) | 0.000 |
| Indirect/deemed interest (units) | 87,976,007 |
| Indirect/deemed interest (%) | 59.040 |
| Date of notice | 06/03/2026 |
| Date notice received by Listed Issuer | 06/03/2026 |
| Remarks : |
| Deemed interest by virtue of his shareholding in Southern Score Builders Berhad ("SSBB"), and indirect interest in SSBB through his shareholding in Super Advantage Property Sdn Bhd, pursuant to Section 8 of the Act. |
Announcement Info
| Company Name | NOVA PHARMA SOLUTIONS BERHAD |
| Stock Name | NPS |
| Date Announced | 06 Mar 2026 |
| Category | Changes in Director's Interest Pursuant to Section 219 of CA 2016 |
| Reference Number | CS4-06032026-00042 |